Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2019

View Archived Issues

Buying time for therapy salvages lungs for transplant

Dynein axonemal heavy chain family identified as chemosensitivity-related genes in gastric cancer

Study confirms the oncogenic role of CDC20 in primary cutaneous squamous cell carcinoma

RPN2 as a biomarker to predict the outcome of chemotherapy for advanced gastric cancer

Small-molecule enhancers of E3 ligase-substrate interaction induce mutant beta-catenin degradation

A novel NOTCH3 mutation associated with epilepsy as an early manifestation of CADASIL

Surfactant protein D restricts HIV-1 passage across vaginal barrier in preclinical models

Tafazzin gene therapy created to treat Barth syndrome

InFlectis BioScience announces phase I results for IFB-088

Bispecific anti-VEGF/ANG-2 surrobody SL-634 shows potential to treat wet AMD

Vertex and Kymera enter strategic research and development collaboration

GABA-selective AAV therapy upregulates SCN1A to treat Dravet syndrome

New stroke therapy promotes motor recovery in mice

Bayer describes new P2X purinoceptor 3 antagonists

FORMA Therapeutics discloses new HDAC6 inhibitors

New phase I trial studies MK-8558 in antiretroviral-naive patients with HIV-1

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

FDA clears IND for Turning Point's TPX-0022

Emory University synthesizes fusion peptides including uPA or EGFR sequences with a toxin

Phase I/II results of DNase eye drops for dry eye disease

Vernalis, Servier present Bcl-2 inhibitors

New TrpC6 antagonists discovered by Hydra Biosciences and Boehringer Ingelheim

NCI studies whether Lixte's LB-100 can penetrate glioblastoma multiforme tumors

M.D. Anderson studies anti-PR1/HLA-A2 monoclonal antibody Hu8F4 in advanced hematologic malignancies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...